Ridwan Shabsigh, MDRidwan Shabsigh, MD
Department of Urology
Columbia-Presbyterian Medical Center
The Atchley Pavilion, 11th floor
161 Fort Washington Avenue
New York, NY 10032 USA
Email: RShabsigh@urology.cpmc.columbia.edu 

Columbia-Presbyterian Hospital Columbia-Presbyterian Eastside 
The Atchley Pavilion, Room 1119 16 East 60th Street 
161 Fort Washington Avenue New York, NY 10022 USA
Tel: +1-212-305-0123 / Fax: +1-212-305-0126
Email: RS66@Columbia.edu 

view presentation | view presentation transcript | view abstract | watch interview video | view interview transcriptprint this page

Academic training:

1970-1976 Damascus University Medical School Damascus, Syria
Aug 12, 1976 MD degree Damascus, Syria
Damascus University Medical School

Licensure:

  • Oklahoma State
  • New York State
  • New Jersey State

Traineeship:

  • 1976-1978 Resident (surgery) Damascus University Hospitals Damascus, Syria
  • 1979-1983 Resident (urology) Seepark Hospital Bremerhaven, Germany
  • 1984-1987 Fellow (urology) Department of Urology Houston, TX
    Baylor College of medicine
    (Dr. F. Brantley Scott's fellowship in urodynamics and genitourinary prostheses)
  • 1987-1990 Resident (urology) Department of Urology Houston, TX
    Baylor College of Medicine

Board certification:

  • 1992 American Board of Urology (diplomate)
  • 1983 German "Specialist in Urology" certification

Professional societies:

  • 1990 American Urological Association
  • 1987 American medical Association
  • 1991 Society for Basic Urologic Research
  • 1991 American College of Surgeons (Fellow)
  • 1993 International Society for Impotence Research
  • 1993 American Urological Association, New York Section
  • 1993 New York Academy of Medicine 
  • 1994 Sexual Medicine Society of North America (founding member)
  • 1995 Societe Internationale d'Urologie
  • 1995 Society of University Urologists
  • 1996 Arab American Medical Society
  • 1996 Ecuadorian Urological Society
  • 1999 Member, Sexual Health Council, American Foundation of Urologic Disease
  • 2003 Member, Research Council, American Urological Association
  • 2004 Member, Board of Directors, Sexual Medicine Society of North America

Academic appointments:

  • 1990-1991 Instructor in Urology Columbia University New York, NY
  • 1991-1998 Assistant professor of urology Columbia University New York, NY
  • 1998-present Associate professor of urology Columbia University New York, NY

Hospital appointments:

  • 1990-1998 Assistant attending NY Presbyterian Hospital New York, NY
  • 1998-present Associate attending NY Presbyterian Hospital New York, NY
  • 1990-1996 attending Helen Hayes Hospital West Haverstraw, NY

Honors:

  • 1989 Harry Spence Resident Prize Essay Contest of the Texas Urological Society
  • 1991 John K. Lattimer Award for Excellence in Clinical Instruction, Columbia University

Grant support:

  • 1993-1994 American Foundation of Urologic Disease (AFUD) young investigator award:
    Effects of denervation and reinnervation on neurotrophins in the rat penis.
  • 1994-1995 Renewal of American Foundation of Urologic Disease (AFUD) young investigator award: 
    Effects of denervation and reinnervation on neurotrophins in the rat penis.
  • 1992-1993 Upjohn clinical trial: investigator. Long term safety study with Alprostadil Sterile Powder 
    (PGE-1) (Alprostadil S. Po.) in patients with erectile dysfunction.
  • 1993-1994 Vivus clinical trial: investigator. Program for treatment of erectile dysfunction with the 
    medicated urethral system for erection (MUSE).
  • 1993-1994 Schwartz-Pharma clinical trial: investigator. Dose-titration efficacy & safety study of Alprostadil Alphadex for erectile dysfunction in diabetics and non-diabetics followed by open label treatment.
  • 1993-1994 Syntex clinical trial: investigator. randomized double-blind placebo controlled parallel study to assess the efficacy and safety of 4 oral dose levels of RS-15385 in men with erectile disorders.
  • 1994-1995 Pentech clinical trial: Principal investigator. Apomorphine HC1, USP sublingual tablet escalating dose tolerance study for the treatment of psychogenic male erectile dysfunction.
  • 1994-1995 Vivus clinical trial: Principal investigator. Double-blind, evaluation of the safety and efficacy of alprostadil for the treatment of erectile dysfunction delivered the medicated urethral system for erection (MUSE).
  • 1994-1995 Vivus clinical trial: investigator. One year open-label evaluation of alprostadil for treatment of erectile dysfunction delivered with the medicated urethral system for erection (MUSE).
  • 1995-1996 Pfizer clinical trial: investigator. Double blind, randomized, placebo controlled, parallel group, fixed dose, multicentre study to assess the efficacy and safety of Sildenafil (UK-92,480) administered over 6 months to male patients with erectile dysfunction.
  • 1996-1997 TAP clinical trial: investigator. Phase III, double blind, randomized, parallel group, 2-cross over, safety and efficacy study of apomorphine SL 2,4, and 6 mg sublingual tablets compared to placebo tablets for the treatment of erectile dysfunction
  • 1996-1997 Pentech clinical trial: investigator. Oral Paroxetine for the treatment of premature ejaculation.
  • 1997-1998 Pfizer clinical trial: Principal investigator. A randomized double-blind study (with open-label treatment extension) to evaluate the efficacy and safety of Viagra in men with symptoms of depression and erectile dysfunction.
  • 1997-1998 TAP clinical trial: investigator. Phase III, efficacy and safety study comparing escalating doses of apomorphine SL tablets to 2 doses (5 mg and 6 mg) of apomorphine SL tablets or placebo in the treatment of erectile dysfunction
  • 1998-1999 TAP clinical trial: investigator. Efficacy and safety study of apomorphine SL tablets comparing a doses 5 mg of apomorphine SL tablets to placebo in the treatment of erectile dysfunction in post radical prostatectomy patients
  • 1998-1999 Machrochem clinical trial: investigator: Efficacy and safety study of prostaglandin E-1 gel 
    for the treatment of erectile dysfunction
  • 1998-1999 Schwartz-Pharma clinical trial: Principal investigator. A comparative multi-center randomized cross- over study of the efficacy and safety of alprostadil alfadex (Edex/Viridal) versus intraurethral alprostadil (MUSE) in the treatment of erectile dysfunction.
  • 1998-1999 Schwartz-Pharma clinical trial: Principal investigator. Multi-center, open-label study of the efficacy and safety of alprostadil alfadex (Edex/Viridal) for the treatment of erectile dysfunction in patients who failed sildenafil (Viagra).
  • 1998-1999 Pharmacia & Upjohn clinical trial: Multi-center, open-label study of the efficacy and safety of alprostadil sterile powder (Caverject) for the treatment of erectile dysfunction in patients who failed Sildenafil (Viagra).
  • 1999-2000 Pentech clinical trial: Principal investigator: Multi-center, randomized, placebo-controlled, double-blind, dose-ranging study of Apomorphine, SL for the treatment of female sexual dysfunction.
  • 2000-2001 Lilly-ICOS clinical trial: investigator. Efficacy and safety study of IC351 (Cialis) tablets in the treatment of erectile dysfunction.
  • 2000-2001 Bayer clinical trial: investigator. Efficacy and safety study of Vardenafil tablets in the treatment of erectile dysfunction in diabetic patients.
  • 2000-2001 Bayer clinical trial: investigator. Efficacy and safety study of Vardenafil tablets in the treatment of erectile dysfunction in post radical prostatectomy patients.
  • 2000-2001 Lilly-ICOS clinical trial: investigator. Efficacy and safety study of IC351 (Cialis) tablets in the treatment of erectile dysfunction.
  • 2000-2002 Partnership in Women’s Health award: localization of the site of action of testosterone in the female brain.
  • 2002-2003 Randomized, double blind, placebo controlled trial of safety and efficacy of flibanserin in females with hypoactive sexual desire disorder.
  • 2000-2002 Depression related improvement with Vardenafil for erectile dysfunction.

Departmental, Hospital & University Committees:

  • 1991-1995 Urology representative, Staff committee of the  Columbia-Presbyterian Medical Center, New York.
  • 1992-1996 Urology representative, Utilization Review Committee of the Columbia-Presbyterian Hospital.
  • 1993-present Urology representative, Columbia-Presbyterian Hospital Task Force on endoscopy.
  • 1993-1996 Director, departmental residency education committee.
  • 1993-present Departmental annual visiting professor coordinator.
  • 1994-present Columbia-Presbyterian Eastside Board of directors.
  • 1995-present Departmental task force on computerized patient record “Paperless Doctor’s Office”
  • 1997-present Director, international urology project
  • 2001-present Co-director, sexual health curriculum project, College of Physicians & Surgeons of Columbia Univ.
  • 2003-present International Society of Sexual and Impotence Research (ISSIR) Standards Committee

Teaching experience & responsibilities:

  • 97-03 Lecturer Annual sexual anatomy and physiology lecture to 2nd year med students Alumni auditorium
  • 03-04 Lecturer Biweekly human sexuality lecture for the 3rd year urology rotation clerkship
  • 6/86 Moderator Annual Meeting German Urological Congress Bremerhaven, Germany
  • 9/87 Faculty Ultrasonography in Urology, AUA seminar San Diego, CA
  • 6/91 Guest faculty Baylor Urology Update, post graduate seminar.  Houston, TX
  • 12/91 Faculty Update on the management of bladder disease.  New York, NY
  • 12/91 Guest speaker Transrectal ultrasound in urology, Maimonides Hospital,  New York, NY 
  • 5/92 Faculty Problems with prosthetic devices, AUA instructional course #69,  Washington, DC
  • 12/92 Faculty Urologic prostheses.  New York, NY
  • 12/92 Guest speaker Surgical treatment of impotence. Maimonides Hospital,  New York, NY
  • 93 Faculty Ultrasound imaging of Peyronie's, NIH conference on Peyronie's disease Washington, DC
  • 3/93 Faculty Treatment of male incontinence, AUA, NY-section post graduate seminar New York, NY
  • 6/93 Director Update in the diagnosis & treatment of impotence, post graduate seminar.  New York, NY
  • 1/94 Faculty Office evaluation of impotence, Non-injection medical therapy of impotence Penile prostheses. Surface coil MRI in staging of prostate cancer.  Winter Urologic Forum post graduate seminar.  Steamboat, CO
  • 1/94 Guest speaker Surgical management of impotence & double implants, Cabrini Hospital,  New York, NY
  • 2/94 Guest speaker Update in GU prostheses, Beth Israel Hospital,  New York, NY
  • 3/94 Faculty Diagnosis and treatment of impotence,  Long Island College of pharmacy & Public Health,  New York, NY 
  • 3/94 Faculty Diagnosis and treatment of impotence. Management of male infertility. Alternative therapies of BPH. Association of Clinical Pharmacologists, Annual Meeting, Session on Urology San Antonio, TX
  • 6/94 Faculty Infection of genitourinary prosthesis 3rd Annual Urology Seminar, American Hospital of Paris Paris, France
  • 6/94 Faculty Medical treatment of impotence, AUA, NY Section Young Urologist Meeting Rye Brook, NY
  • 11/94 Faculty Sexual dysfunction and Parkinson's disease, Meeting on Parkinson's disease, Columbia-  Presbyterian medical Center. New York, NY
  • 3/95 Visiting 1 week visiting professorship professor Kiev Institute of Urology & Nephrology The AUA International Cooperative Urologic Education Project
  • 3/95 Guest speaker Innovations in the management of impotence, Lenox Hill Hospital,  New York, NY
  • 4/95 Guest speaker Update in the treatment of impotence, Winthrop Hospital, Long Island Winthrop, NY
  • 6/95 Faculty Intracavernous injections for the management of erectile dysfunction in patients with Peyronie's disease. Ultrasound in the diagnosis of Peyronie's disease. 6th International Meeting of Andrology.  Universita Urbano Vaticano  Rome, Italy
  • 11/95 Visiting Seminar on impotence and Peyronie’s disease. Professor Achim, Germany
  • 12/95 Director Diagnosis and treatment of erectile dysfunction, a guide to primary care practitioners New York, NY
  • 3/96 Co-Director Erectile dysfunction, intracavernosal pharmacotherapy, Multidisciplinary perspective, international seminar Universal City, CA
  • 5/96 Speaker Medical update: Male potency problems Annual Meeting of the American Psychiatric Association New York, NY
  • 7/96 Visiting Hospitals of the Adighe Autonomous Republic professor Maikop, Russia
  • 8/96 Faculty 11th International Course in Urology Quito, Ecuador
  • 10/96 Faculty Do pills & creams cure impotence?, AUA, NY-section annual meeting Paris, France
  • 10/96 Faculty Update on penile prosthesis, AUA, NY-section annual meeting Paris, France
  • 11/96 Director Diagnosis and treatment of erectile dysfunction, an update New York, NY
  • 3/97 Speaker Non surgical therapy of erectile dysfunction Post graduate seminar, NY Academy of Medicine, NY Section AUA. New York, NY
  • 6/97 Director Update on sexual dysfunction, satellite seminar New York, NY
  • 8/97 Speaker Erectile dysfunction, a seminar for primary care physicians Anaheim, CA
  • 9/97 Co-director Male sexual dysfunction, 2nd international seminar Universal City, CA
  • 9/97 Co-director Building a therapeutic alliance, an interactive seminar Universal City, CA
  • /97 Faculty Asia/Pacific Society for Impotence Research, biennial meeting Kuala Lumpur, Malaysia
  • 10/97 Faculty AFUD & NIH Science writer conference. National Institutes of Health Bethesda, MD
  • 12/97 Faculty Consensus Panel on the Diagnosis & Treatment of Erectile Dysfunction New York, NY
  • 2/98 Faculty Diagnosis and Treatment of Erectile Dysfunction Royal College of Physicians London, United Kingdom
  • 3/98 Guest speaker El Colegio Mexicano de Urologia, annual meeting, Monterrey, Mexico
  • 8/98 Faculty Biennial meeting of the International Society of Impotence Research Amsterdam, The Netherlands
  • 9/98 Guest speaker Annual meeting of the Italian Society of Andrology Perugia, Italy
  • 9/98 Guest faculty Innovations in urologic practice, Baylor College of Medicine Santa Fe, NM
  • 10/98 Co-director Male sexual dysfunction, 3rd international seminar Universal City, CA
  • 10/98 Faculty AFUD & NIH Science writer conference. National Institutes of Health Bethesda, MD
  • 10/98 Faculty AFUD Consensus Panel on Female Sexual Dysfunction Boston, MA
  • 2/99 Guest faculty African Society of Impotence Research Cairo, Egypt
  • 5/99 Speaker Society for the Study of Impotence annual meeting Dallas, TX
  • 7/99 Committee Economical Aspects of ED. International Consultation on ED Chairman sponsored by the World Health Organization, Paris, France
  • 10/99 Co-director Male sexual dysfunction, 4th international seminar Beverley Hills, CA
  • 2/2000 Guest Alprostadil Alphadex injection therapy versus intraurethral suppository speaker a comparative study, European Society for Impotence Research Barcelona, Spain
  • 3/2000 Guest faculty 1st Mediterranean Congress on Sexual Dysfunction Cairo, Egypt
  • 4/2000 Director Advances in the treatment in erectile dysfunction, CME seminar Atlanta, GA
  • 5/2000 Faculty AUA course: Diagnosis & management of erectile dysfunction.
  • 6/2000 Director Sexual Dysfunction 2000 Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD New York, NY
  • 11/2000 Co-chairman Male sexual dysfunction, 5th international seminar Beverley Hills, CA
  • 2/2001 Guest faculty 14th Annual meeting of the Saudi Urological Society Dammam, Saudi Arabia
  • 5/2001 Director Sexual Dysfunction 2001 Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD New York, NY
  • 6/2001 Director Challenges & solutions in ED, CME seminar Anaheim, CA
  • 6/2001 Director AUA course: Update on ED.
  • 10/2001 Faculty European Society for Sexual & Impotence Research (ESSIR) biennial meeting Rome, Italy
  • 11/2001 Co-chairman Male sexual dysfunction, 6th international seminar Beverley Hills, CA
  • 2/2002 Guest faculty AUA NY Section Special AUA 100th anniversary meeting New York, NY
  • 3/2002 Faculty American College of Cardiology, Erectile Dysfunction symposium Atlanta, GA
  • 2/2002 Faculty AUA NY Section Special AUA 100th anniversary meeting New York, NY
  • 5/2002 Director Challenges & solutions in ED, CME seminar Orlando, FL
  • 6/2002 Director Sexual Dysfunction 2002 Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD New York, NY
  • 7/2002 Faculty 3rd International Conference on the Management of ED McLean, VA
  • 10/2002 Visiting Department of Urology, Pennsylvania State University professor Hershey, PA
  • 10/2002 Faculty AUA NY Section Annual meeting Madrid, Spain
  • 11/2002 Co-chairman Male sexual dysfunction, 7th international seminar Beverley Hills, CA
  • 11/2002 Faculty Update on ED seminar, Jefferson Medical College Philadelphia, PA
  • 12/2002 Guest faculty European Society for Sexual and Impotence Research  Hamburg, Germany
  • 12/2002 Faculty Science Writers Conference, American Foundation of Urologic Disease New York Academy of Medicine New York, NY
  • 2001-2002 Director Uro Blue Stage, Columbia University international urology seminar hosted six 3-day seminars with a total of 180 urologists from Italy  Closed circuit transmission from OR and interactive lectures New York, NY
  • 2/2003 Chairman Chief resident debate, AUA NY Section / NY Academy of Medicine  New York, NY

Member, editorial board

  • Sexual Dysfunction in Medicine, Remedica Publishing 
  • Medical Aspects of Human Sexuality, Quadrant HealthCom, Inc

Member, editorial review board

  • Journal of Urology, Lippincott Williams & Wilkins 
  • Urology, Elsevier

continued

<< click to view all presentations